Cough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus Farhat Nasim26 April 2025 1:39 PMNew Delhi: In a major relief to pharma companies Glenmark Pharmaceuticals Ltd. and Zuventus Healthcare Ltd., the Delhi High Court has ruled that the...
Health Ministry Bans Chlorpheniramine Phenylephrine Combo for Children Below 4, Mandates Warning Labels Farhat Nasim17 April 2025 12:39 PMNew Delhi: Through a recent Gazette Notification, the Ministry of Health and Family Welfare has officially restricted the use of the widely available...
Decades Old FDCs Under Review: DCGI Demands Proof of Efficacy Farhat Nasim28 Feb 2025 11:37 AMCDSCO has given manufacturers a final 3-month deadline to submit required data or face regulatory action, including license cancellation.
DCGI bans this popular anti-cold FDC for children under 4 Farhat Nasim14 Oct 2024 10:55 AMNew Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...
Glenmark gets CDSCO Panel nod to Study FDC Of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin12 Dec 2022 12:30 PMNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to drug...
Dr Reddys acquires injectable product portfolio from Eton Pharma for Rs 391 crore Ruchika Sharma25 Jun 2022 6:19 AM"The acquisition supports Dr. Reddy's efforts to accelerate and expand affordable medications for patients," the company stated.
Justify dose of Bilastine: CDSCO Panel tells Glenmark on FDC of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin17 May 2022 1:40 PMNew Delhi: Rejecting the pharmaceuticals major Glenmark proposal for bioequivalence (BE) study waiver of fixed dose combination drug Bilastine 3.3mg...
